Marin-Acevedo JA - Search Results

1

Hypereosinophilia in a patient with metastatic non-small-cell lung cancer treated with antiprogrammed cell death 1 (anti-PD-1) therapy.

Lou Y, Marin-Acevedo JA, Vishnu P, Manochakian R, Dholaria B, Soyano A, Luo Y, Zhang Y, Knutson KL. Lou Y, et al. Immunotherapy. 2019 May;11(7):577-584. doi: 10.2217/imt-2018-0128. Immunotherapy. 2019. PMID: 30943864

2

Next generation of immune checkpoint therapy in cancer: new developments and challenges.

Marin-Acevedo JA, Dholaria B, Soyano AE, Knutson KL, Chumsri S, Lou Y. Marin-Acevedo JA, et al. J Hematol Oncol. 2018 Mar 15;11(1):39. doi: 10.1186/s13045-018-0582-8. J Hematol Oncol. 2018. PMID: 29544515 Free PMC article. Review.

3

Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodies.

Soyano AE, Dholaria B, Marin-Acevedo JA, Diehl N, Hodge D, Luo Y, Manochakian R, Chumsri S, Adjei A, Knutson KL, Lou Y. Soyano AE, et al. J Immunother Cancer. 2018 Nov 23;6(1):129. doi: 10.1186/s40425-018-0447-2. J Immunother Cancer. 2018. PMID: 30470260 Free PMC article.

4

Next generation of immune checkpoint inhibitors and beyond.

Marin-Acevedo JA, Kimbrough EO, Lou Y. Marin-Acevedo JA, et al. J Hematol Oncol. 2021 Mar 19;14(1):45. doi: 10.1186/s13045-021-01056-8. J Hematol Oncol. 2021. PMID: 33741032 Free PMC article. Review.

5

Immunotherapies targeting stimulatory pathways and beyond.

Marin-Acevedo JA, Kimbrough EO, Manochakian R, Zhao Y, Lou Y. Marin-Acevedo JA, et al. J Hematol Oncol. 2021 May 12;14(1):78. doi: 10.1186/s13045-021-01085-3. J Hematol Oncol. 2021. PMID: 33980266 Free PMC article. Review.

6

Cancer immunotherapy beyond immune checkpoint inhibitors.

Marin-Acevedo JA, Soyano AE, Dholaria B, Knutson KL, Lou Y. Marin-Acevedo JA, et al. J Hematol Oncol. 2018 Jan 12;11(1):8. doi: 10.1186/s13045-017-0552-6. J Hematol Oncol. 2018. PMID: 29329556 Free PMC article. Review.

7

Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia.

Kumar V, Ailawadhi S, Bojanini L, Mehta A, Biswas S, Sher T, Roy V, Vishnu P, Marin-Acevedo J, Alegria VR, Paulus A, Aulakh S, Iqbal M, Manochakian R, Tan W, Chanan-Khan A, Ailawadhi M. Kumar V, et al. Blood Cancer J. 2019 Sep 30;9(10):75. doi: 10.1038/s41408-019-0237-1. Blood Cancer J. 2019. PMID: 31570695 Free PMC article.

8

Immunotherapy for Advanced Non-Small Cell Lung Cancer: A Decade of Progress.

Shields MD, Marin-Acevedo JA, Pellini B. Shields MD, et al. Among authors: marin acevedo ja. Am Soc Clin Oncol Educ Book. 2021 Mar;41:1-23. doi: 10.1200/EDBK_321483. Am Soc Clin Oncol Educ Book. 2021. PMID: 33979196 Free article.

9

Biomarkers of hyperprogression and pseudoprogression with immune checkpoint inhibitor therapy.

Failing JJ, Dudek OA, Marin Acevedo JA, Chirila RM, Dong H, Markovic SN, Dronca RS. Failing JJ, et al. Among authors: marin acevedo ja. Future Oncol. 2019 Aug;15(22):2645-2656. doi: 10.2217/fon-2019-0183. Epub 2019 Jul 12. Future Oncol. 2019. PMID: 31298573

10

Immune Checkpoint Inhibitor Toxicities.

Marin-Acevedo JA, Chirila RM, Dronca RS. Marin-Acevedo JA, et al. Mayo Clin Proc. 2019 Jul;94(7):1321-1329. doi: 10.1016/j.mayocp.2019.03.012. Mayo Clin Proc. 2019. PMID: 31272574 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page